Spermicide use and pregnancy outcome

Area of Science:

• Reproductive Health
• Obstetrics
• Perinatal Epidemiology

Background:

• Vaginal spermicides are widely used for contraception.
• Concerns exist regarding potential adverse effects on pregnancy outcomes.
• Understanding the safety profile of periconceptional spermicide use is crucial.

Purpose of the Study:

• To investigate the association between periconceptional spermicide use and sex ratio at birth.
• To evaluate the relationship between spermicide exposure and congenital anomalies.
• To assess the impact of periconceptional spermicide use on infant birthweight.

Main Methods:

• Cohort study of 2,712 New York City obstetric patients.
• Categorization of patients based on periconceptional spermicide use (yes/no).
• Analysis of sex ratio, congenital anomaly frequency, and birthweight in relation to spermicide exposure.

Main Results:

• No significant association found between periconceptional spermicide use and sex ratio at birth.
• No increased risk of major or minor congenital anomalies linked to spermicide exposure.
• No impact on birthweight for male or female infants with dichotomous spermicide exposure.
• A minor decrease in female infant birthweight observed with increasing duration of postconceptional spermicide use (7.4g/day), considered a potential chance finding.

Conclusions:

• Periconceptional spermicide use does not appear to increase the risk of adverse birth outcomes like congenital anomalies or altered sex ratios.
• The observed slight decrease in birthweight among female infants with prolonged postconceptional exposure warrants further investigation but may be a chance finding.
• Current evidence suggests spermicide use around conception is not associated with major risks to fetal development.